More Post from the Author
- Coastal Mississippi Elevates Ari Covacevich to Lead Sales & Business Development
- Adventure Isn't Just For the Backcountry - Storyteller Overland Brings Badassery To The Big Apple
- Cunard reveals first phase of 2026 Event Voyages program
- Unifi expands UK Operations with Ground Handling and Security Contracts at London Oxford Airport
- United Airlines Reports Best First-Quarter Financial Performance in Five Years Despite Challenging Macroeconomic Environment
AdventHealth Tampa is first in Tampa Bay to offer implantable chemotherapy pump for patients with metastatic colorectal cancer
Published on Wed 19 Mar 2025 9:40:06 UTC

Hepatic Artery Infusion therapy delivers treatment directly tometastatic tumors in the liver, while minimizing the potential for systemic side effects
TAMPA, Fla., March 18, 2025 /PRNewswire/ -- AdventHealth Tampa is the first in the Tampa Bay area to offer a powerful new pump-based treatment option for colorectal cancer that has spread to the liver and for a rare form of cancer that forms in bile ducts within the liver called intrahepatic cholangiocarcinoma.
Hepatic Artery Infusion (HAI) therapy uses a pump that is implanted just below the skin in a patient's abdominal wall to deliver medicine directly to the liver through the hepatic artery, maximizing drug delivery to the tumors without adding systemic side effects.
More Post from the Author
- Coastal Mississippi Elevates Ari Covacevich to Lead Sales & Business Development
- Adventure Isn't Just For the Backcountry - Storyteller Overland Brings Badassery To The Big Apple
- Cunard reveals first phase of 2026 Event Voyages program
- Unifi expands UK Operations with Ground Handling and Security Contracts at London Oxford Airport
- United Airlines Reports Best First-Quarter Financial Performance in Five Years Despite Challenging Macroeconomic Environment